|
You
are here: Home: BCU 5|2001: Section 2: Select publications
Select
Publications
Dixon JM et al.The effects of neoadjuvant anastrozole (Arimidex)on
tumor volume in postmenopausal women with breast cancer:A randomized,
double-blind,single-center study. Clin Cancer Res 2000;6(6):2229-35.
Abstract
El-Didi MH et al. Pathological assessment of the response of
locally advanced breast cancer to neoadjuvant chemotherapy and its
implications for surgical management. Surg Today 2000;30:249-54.
Abstract
Ellis MJ et al. Letrozole is more effective neoadjuvant endocrine
therapy than tamoxifen for ErbB-1-and/or ErbB-2-positive,estrogen
receptor-positive primary breast cancer:Evidence from a phase III
randomized trial. J Clin Oncol 2001;19:3808-3816. Abstract
Fisher B et al. Effect of preoperative chemotherapy on the outcome
of women with operable breast cancer. J Clin Oncol 1998;16(8):2672-2685.
Abstract
Geisler J et al. Influence of neoadjuvant anastrozole (Arimidex)
on intratumoral estrogen levels and proliferation markers in patients
with locally advanced breast cancer. Clin Cancer Res
2001;7(5):1230-6. Abstract
Goldstein NS et al. Intraductal carcinoma of the breast:Pathologic
features associated with local recurrence in patients treated with
breast-conserving therapy. Am J Surg Pathol 2000;24(8):1058-67.
Abstract
Jakesz R. Comparison of pre-vs.postoperative chemotherapy in
breast cancer patients: Four-year results of Austrian Breast &Colorectal
Study Group (ABCSG)Trial 7. Proc ASCO 2001; Abstract125.
Kuerer HM et al. Neoadjuvant chemotherapy in women with invasive
breast carcinoma: Conceptual basis and fundamental surgical issues.
J Am Coll Surg 2000;190(3):350-363. No Abstract Available.
Return
|
|
